Experimental drugs on patients

On March 21, 2018, the United States House of Representatives passed a bill allowing patients the right to try experimental drugs prior to Food and Drug administration approval. Discuss the ethical principles of beneficence (doing good) and non-maleficence (avoiding causing harm), and issues of the morality of a legal system that delays research because of the legal rights of patent holders. Describe how you would handle this ethical issue with your patients.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *